AptarGroup Inc (ATR)

NYSE
Currency in USD
158.93
-1.13(-0.70%)
Real-time Data·
ATR Scorecard
Full Analysis
Has raised its dividend for 32 consecutive years
ATR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
158.10160.64
52 wk Range
130.85178.03
Key Statistics
Edit
Prev. Close
160.05
Open
160.64
Day's Range
158.1-160.64
52 wk Range
130.85-178.03
Volume
131.39K
Average Vol. (3m)
352.03K
1-Year Change
13.1%
Book Value / Share
38.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
175.00
Upside
+10.11%
Members' Sentiments
Bearish
Bullish
ProTips
6 analysts have revised their earnings upwards for the upcoming period

AptarGroup Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

AptarGroup Inc Company Profile

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Employees
13500

AptarGroup Inc SWOT Analysis


Strategic Challenges
Learn about ATR's navigation of raw material costs, currency fluctuations, and competitive pressures in the evolving packaging industry
Market Momentum
Discover how ATR's 39.32% YTD return and analyst projections of $5.35-$6.00 EPS for FY24-25 reflect its strong market position
Financial Fortitude
Delve into ATR's robust balance sheet, with net debt to EBITDA at 1x, enabling strategic investments and consistent dividend increases
Pharma Powerhouse
Explore AptarGroup's dominance in drug delivery systems, driving growth through innovation in biologics packaging and elastomeric components
Read full SWOT analysis

AptarGroup Inc Earnings Call Summary for Q1/2025

  • AptarGroup Q1 2025: EPS $1.20 beats $1.16 forecast; revenue $887M misses $929.07M estimate; stock up 0.34% after-hours
  • Pharma segment core sales up 3%; flat overall core sales; adjusted EBITDA grew 3% YoY to $183M; free cash flow $26M
  • Q2 2025 guidance: EPS $1.56-$1.64, tax rate 19-21%; long-term Pharma growth target 7-11%; new product launches planned
  • CEO highlights resilience amid economic uncertainty; focus on essential products; analysts query inventory destocking, GLP-1 demand
  • Risks: supply chain disruptions, market saturation, macroeconomic pressures, tariff changes, cold/cough market inventory destocking
Last Updated: 05/02/2025, 10:06 AM
Read Full Transcript

Compare ATR to Peers and Sector

Metrics to compare
ATR
Peers
Sector
Relationship
P/E Ratio
28.4x14.6x2.1x
PEG Ratio
1.640.220.00
Price / Book
4.1x1.2x1.6x
Price / LTM Sales
3.0x1.1x1.3x
Upside (Analyst Target)
7.8%2.9%22.0%
Fair Value Upside
Unlock8.8%2.3%Unlock

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 175.00
(+10.11% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.58%
Dividend Yield
1.12%
Annualized Payout
1.80
Paid quarterly
5-Years Growth
+4.10%
Growth Streak

Earnings

Latest Release
May 01, 2025
EPS / Forecast
1.20 / 1.16
Revenue / Forecast
887.00M / 929.07M
EPS Revisions
Last 90 days

ATR Income Statement

People Also Watch

119.26
ATGE
-0.62%
92.54
SEIC
+0.16%
302.00
UNH
-1.85%
409.82
CSL
+2.29%
107.66
BRO
+0.38%

FAQ

What Is the AptarGroup (ATR) Stock Price Today?

The AptarGroup stock price today is 158.93

What Stock Exchange Does AptarGroup Trade On?

AptarGroup is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for AptarGroup?

The stock symbol for AptarGroup is "ATR."

Does AptarGroup Pay Dividends? What’s The Current Dividend Yield?

The AptarGroup dividend yield is 1.12%.

What Is the AptarGroup Market Cap?

As of today, AptarGroup market cap is 10.51B.

What Is AptarGroup's Earnings Per Share (TTM)?

The AptarGroup EPS (TTM) is 5.58.

When Is the Next AptarGroup Earnings Date?

AptarGroup will release its next earnings report on Jul 31, 2025.

From a Technical Analysis Perspective, Is ATR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has AptarGroup Stock Split?

AptarGroup has split 2 times.

How Many Employees Does AptarGroup Have?

AptarGroup has 13500 employees.

What is the current trading status of AptarGroup (ATR)?

As of Jul 09, 2025, AptarGroup (ATR) is trading at a price of 158.93, with a previous close of 160.05. The stock has fluctuated within a day range of 158.10 to 160.64, while its 52-week range spans from 130.85 to 178.03.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.